Table 1 of
Payne, Mol Vis 2011; 17:2318-2324. Table 1 of
Payne, Mol Vis 2011; 17:2318-2324.
Table 1. Clinical characteristics of the four study groups.
Clinical characteristic |
No DM (n=99) |
No BDR (n=42) |
NPDR (n=41) |
PDR (n=43) |
p-value |
|---|---|---|---|---|---|
| Age (years)* | 61.5±12.6 | 62.4±11.2 | 68.4±9.9 | 59.8±11.8 | 0.708 |
| Race: Black | 48 (49%) | 21 (50%) | 22 (54%) | 23 (54%) | 0.964 |
| White | 49 (49%) | 19 (45%) | 18 (44%) | 19 (44%) | |
| Asian | 2 (2%) | 2 (5%) | 1 (2%) | 1 (2%) | |
| Sex: Male | 49 (49%) | 22 (52%) | 22 (54%) | 22 (51%) | 0.971 |
| Body Mass Index* (kg/m2) | 28.4±7.1 | 31.7±9.6 | 31.3±6.6 | 33.0±6.7 | <0.001 |
| Duration of Diabetes (years)* | - | 7.5±7.7 | 19.2±11.1 | 22.2±10.5 | <0.001 |
| Hemoglobin A1c* | 5.8±0.4 | 7.5±1.9 | 7.4±1.2 | 8.1±1.8 | <0.001 |
| Insulin Usage | - | 10 (24%) | 30 (73%) | 31 (72%) | <0.001 |
| Macrovascular Disease | 13 (13%) | 6 (14%) | 14 (33%) | 19 (44%) | <0.001 |
| Hypertension | 56 (57%) | 28 (67%) | 39 (95%) | 40 (93%) | <0.001 |
| Serum Creatinine* (mg/dl) | 0.99±0.64 | 0.92±0.28 | 1.90±1.85 | 2.50±2.78 | <0.001 |
| Estimated GFR* (ml/min/1.73m2) | 82.22±24.01 | 89.00±29.76 | 58.32±31.78 | 47.70±29.87 | <0.001 |